Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes

P Guo, T Teng, W Liu, Y Fang, B Wei… - … Journal of Cancer, 2022 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is characterized by high heterogeneity, and the
postoperative prognosis of different patients often varies greatly. Therefore, the classification …
被引用次数：9 相关文章

Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes.

P Guo, T Teng, W Liu, Y Fang, B Wei… - … Journal of Cancer, 2022 - search.ebscohost.com
Pancreatic ductal adenocarcinoma (PDAC) is characterized by high heterogeneity, and the
postoperative prognosis of different patients often varies greatly. Therefore, the classification …

Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes

P Guo, T Teng, W Liu, Y Fang, B Wei… - … journal of cancer, 2022 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is characterized by high heterogeneity, and the
postoperative prognosis of different patients often varies greatly. Therefore, the classification …

Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes.

P Guo, T Teng, W Liu, Y Fang, B Wei… - International Journal of …, 2022 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is characterized by high heterogeneity, and the
postoperative prognosis of different patients often varies greatly. Therefore, the classification …
[PDF] researchgate.net

[PDF][PDF] Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes

P Guo, T Teng, W Liu, Y Fang, B Wei, J Feng, H Huang - researchgate.net
Pancreatic ductal adenocarcinoma (PDAC) is characterized by high heterogeneity, and the
postoperative prognosis of different patients often varies greatly. Therefore, the classification …